Top companies

ASIANPAINT - 2282.35 (-0.41%) AXISBANK - 1071.85 (-3.34%) BAJAJFINSV - 1569.65 (-1.25%) BAJFINANCE - 6848.25 (-1.02%) BHARTIARTL - 1578.1 (-1.39%) BPCL - 289.05 (-1.87%) COALINDIA - 382 (-2.54%) HDFCBANK - 1771.5 (-1.23%) HEROMOTOCO - 4339.95 (-1.52%) HINDUNILVR - 2333.9 (-1.1%) ICICIBANK - 1288.4 (0.12%) INDUSINDBK - 929.45 (-3.62%) ITC - 464.65 (-0.41%) KOTAKBANK - 1743.55 (-1.05%) MARUTI - 10901.05 (-0.5%) ONGC - 237.1 (-1.96%) RELIANCE - 1205.3 (-2.04%) SBIN - 812 (-2.5%) TATAMOTORS - 724.05 (-2.69%) TATASTEEL - 140.68 (-1.8%) TCS - 4170.3 (-2.38%) TITAN - 3356.25 (-0.02%) WIPRO - 305.2 (-2.41%)

Quick Menu

TRENDING #BANK NIFTY 149 #ADANIPORTS 86 #ZOMATO 72

The page of SPARC. Captures the information on Price and Volume for the stock. It also contains the Live Stock Price and Volume, 52 Week High Low and Volume data.Intradaystock prediction for today 23-12-2024 is predicted based on technical analysis and should only be used as reference for learning purpose only.

Sector: Pharmaceuticals

Sun Pharma Advanced Research Company Limited

206.37   -8.12 (-3.79%)

As on 22 Dec, 2024 08:30 IST
Open 215.96
LTP 206.37
Previous Close 214.49
Day High 218.39
Day Low 205.15
Volume 856696

SPARC Prediction / Intraday Stock Price Target

Disclaimer :- Intraday Stock & Index Prediction Levels are been generated everyday at 17:00 Hours for the next trading day. Stock or Index Prediction is done based on technical & strategic levels of the stock or index & can only be used as reference for study of charts & volume patterns. GrowMudra strictly recommends everyone to consult a certified financial advisor before initiating any trade in the stock market. GrowMudra strictly forbids anyone to take the above views as advisory & holds no responsibility on any financial losses or gain.

Peers

Company Name Price Change % Chg Day High Day Low Previous Close Volume
Sun Pharma Advanced Research Company Limited 0 0 0 0 0 0 0
Syncom Healthcare Limited 0 0 0 0 0 0 0

About Company

Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology, neurodegeneration, and Immunology. The company's products under development include Elepsia XR for the treatment of epilepsy; PDP-716 for the treatment of open-angle glaucoma; and Sezaby for the treatment of neonatal seizures. In addition, it is developing Vodobatinib (SCC-138), a c-ABL inhibitor, which is in phase 2 clinical trial to treat Parkinson's disease; has completed phase 1 clinical trial for the treatment of lewy body dementia; and in preclinical trial to treat alzheimer's disease. Further, the company develops Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. Additionally, it is developing SCD-153 for the treatment of alopecia areata and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.

 

Top Gainers

Company LTP Change Gain
ICICI-Bank-Limited 1288.4 1.5 0.12 %
Titan-Company 3356.25 -0.6 -0.02 %

Top Losers

Company LTP Change Loss
IndusInd-Bank 929.45 -34.95 -3.62 %
Axis-Bank-Limited 1071.85 -37.05 -3.34 %

Growmudra © 2024 all right reserved

Partner With Us